SCHEMBL3533218

SCHEMBL3533218

COc1cc2ncnc(N(NC(=O)c3ccccc3)c3ccccc3)c2cc1O

nearest known ligand 0.53

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
AURKB Q96GD4 4/20 0.53
CSF1R P07333 4/20 0.51
EGFR P00533 11/20 0.50
AURKA O14965 2/20 0.50
PDGFRB P09619 1/20 0.50
PDGFRA P16234 1/20 0.50
RET P07949 1/20 0.47
KIF5B P33176 1/20 0.47
KDR P35968 1/20 0.47
KMT2A Q03164 1/20 0.46
MAPK14 Q16539 7/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3531811 0.96 AURKB (0.58) AURKBCSF1REGFRAURKAPDGFRB
SCHEMBL27477737 0.93 CSF1R (0.60) AURKBCSF1REGFRAURKAPDGFRB
Hydrochloric Acid SCHEMBL3533954 0.87 EGFR (0.55) AURKBCSF1REGFRAURKAPDGFRB
SCHEMBL3529627 0.86 CSF1R (0.53) AURKBCSF1REGFRAURKAPDGFRB
SCHEMBL3530827 0.85 AURKB (0.61) AURKBCSF1REGFRAURKAPDGFRB
SCHEMBL3533697 0.84 EGFR (0.51) AURKBCSF1REGFRAURKAPDGFRB
SCHEMBL3534089 0.84 EGFR (0.51) AURKBCSF1REGFRAURKAPDGFRB
SCHEMBL28842308 0.84 CSF1R (0.53) AURKBCSF1REGFRAURKAPDGFRB
SCHEMBL3531491 0.83 CSF1R (0.49) AURKBCSF1REGFRAURKAPDGFRB
SCHEMBL3627701 0.82 CSF1R (0.45) AURKBCSF1REGFRAURKAPDGFRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7709479-B1 Quinazoline derivatives and their use as pharmaceuticals ASTRAZENECA (SE) 2010-05-04 US disclosed
EP-1218354-A1 QUINAZOLINE DERIVATIVES AND THEIR USE AS PHARMACEUTICALS AstraZeneca AB (SE) 2002-07-03 EP disclosed
WO-2001021596-A1 QUINAZOLINE DERIVATIVES AND THEIR USE AS PHARMACEUTICALS ASTRAZENECA AB (SE) 2001-03-29 WO disclosed